More than 200 Andalusian patients participate in the largest European research study on autoimmune diseases

A total of 210 patients from different public hospitals in Andalusia are participating in the largest research project currently underway on immune-mediated diseases, known as 3TR (Taxonomy, Treatment, Targets and Remission), coordinated by Marta Alarcón Riquelme, a researcher at the Fundación Progreso y Salud and scientific director of the GENYO research centre in Granada.

This project, which recently held its annual meeting at the University of Barcelona’s Paraninfo, brought together more than a hundred researchers, clinicians, patients and representatives of the pharmaceutical industry in Barcelona to present the main scientific advances of the project, which aims to improve knowledge about six autoimmune diseases and facilitate the development of personalised treatments.

Uno de los aspectos más destacados fue el progreso en el reclutamiento de pacientes, que ya supera las expectativas iniciales en varios países europeos y que es esencial para unos resultados que avancen en el conocimiento y abordaje de estas patologías. El proyecto cuenta actualmente con 45 centros de reclutamiento en Europa y ha incorporado más de 2400 pacientes. En particular, Andalucía ha tenido un papel fundamental en esta fase, gracias a la labor coordinada de los equipos clínicos y de investigación de la sanidad pública andaluza, a través de la Fundación Pública Andaluza Progreso y Salud.

One of the most notable aspects was the progress made in patient recruitment, which has already exceeded initial expectations in several European countries and is essential for results that advance knowledge and treatment of these diseases. The project currently has 45 recruitment centres in Europe and has enrolled more than 2,400 patients. Andalusia has played a particularly important role in this phase, thanks to the coordinated work of the clinical and research teams of the Andalusian public health system, through the Fundación Pública Progreso y Salud. 

3TR Project

The 3TR project, funded by the European Innovative Medicines Initiative (IMI-JU2) and coordinated from Granada, addresses the health challenge of why many patients with autoimmune, inflammatory or allergic diseases do not respond to current treatments. To this end, the consortium brings together 69 entities from 15 countries and analyses data and samples (tissue, blood, faeces, other fluids) from tens of thousands of patients with seven key diseases such as lupus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, asthma and COPD.

Read the full article: https://www.juntadeandalucia.es/organismos/sanidadpresidenciayemergencias/servicios/actualidad/noticias/detalle/623188.html